JB
Therapeutic Areas
Yaqrit Pipeline
| Drug | Indication | Phase |
|---|---|---|
| YAQ006 & YAQ007 | Hepatic Encephalopathy (HE) recurrence; Urea Cycle Disorders (UCD) | Development |
| YAQ001 | Decompensated Cirrhosis; Primary Sclerosing Cholangitis (PSC) with Inflammatory Bowel Disease (IBD) | Proof-of-Concept/Phase 2 |
| YAQ005 | Acute-on-Chronic Liver Failure (ACLF) grades 1 & 2 | Development |
| YAQ002 (Dialive) | Acute-on-Chronic Liver Failure (ACLF) grades 2 & 3 | Development |